Mark Vignola, Ph.D.
Chief Financial Officer

Mark Vignola, Ph.D. has served as our Chief Financial Officer since August 2020. Previously, he served as the Chief Financial Officer of Applied Therapeutics from May 2019 to May 2020. Before that, Dr. Vignola served as the Head of Corporate Development from January 2018 to May 2019, and the Head of Investor Relations from June 2015 to January 2018 at Intercept Pharmaceuticals. Dr. Vignola received his undergraduate degree in Biology from Boston College, and his Master’s degree in Coastal Environmental Management and Ph.D. in Molecular Genetics & Microbiology from Duke University.